78 related articles for article (PubMed ID: 1508119)
1. [Chronic intermittent urokinase therapy in inoperable end-stage coronary disease with therapy refractory angina pectoris symptoms].
Leschke M; Mecklenbeck W; Strauer BE
Med Klin (Munich); 1992 Jul; 87(7):385-9. PubMed ID: 1508119
[No Abstract] [Full Text] [Related]
2. Low-dose intermittent urokinase therapy in chronic symptomatic end-stage arterial disease--clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease.
Leschke M; Schoebel FC; Strauer BE
Clin Hemorheol Microcirc; 1997; 17(1):59-66. PubMed ID: 9181759
[TBL] [Abstract][Full Text] [Related]
3. Chronic-intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris--a pilot study.
Schoebel FC; Leschke M; Jax TW; Stein D; Strauer BE
Clin Cardiol; 1996 Feb; 19(2):115-20. PubMed ID: 8821421
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of the anti-ischemic effect in patients with therapy refractory angina pectoris in end-stage coronary heart disease--results of chronic intermittent urokinase therapy].
Schoebel FC; Peters AJ; Schannwell CM; Holz B; Jax TW; Leschke M; Strauer BE
Z Kardiol; 1998; 87 Suppl 2():188-92. PubMed ID: 9827480
[TBL] [Abstract][Full Text] [Related]
5. [Chronic intermittent urokinase therapy: anti-ischemic and hemodynamic effects].
Leschke M; Schoebel FC; Schannwell CM; Peters AJ; Jax TW; Mecklenbeck W; Strauer BE
Z Kardiol; 1997; 86 Suppl 1():85-94. PubMed ID: 9173724
[TBL] [Abstract][Full Text] [Related]
6. [Conservative therapeutic approaches in terminal coronary heart disease. Chronic intermittent urokinase therapy].
Leschke M; Schoebel FC; Jax TW; Schannwell CM; Marx R; Strauer BE
Herz; 1997 Oct; 22(5):262-71. PubMed ID: 9441157
[TBL] [Abstract][Full Text] [Related]
7. Long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: a randomized dose-response trial.
Leschke M; Schoebel FC; Mecklenbeck W; Stein D; Jax TW; Müller-Gärtner HW; Strauer BE
J Am Coll Cardiol; 1996 Mar; 27(3):575-84. PubMed ID: 8606267
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic treatment in stable coronary syndromes: long-term intermittent urokinase therapy in end-stage coronary artery disease and refractory angina pectoris.
Schoebel FC; Jax TW; Fischer Y; Strauer BE; Leschke M
Heart; 1997 Jan; 77(1):13-7. PubMed ID: 9038688
[TBL] [Abstract][Full Text] [Related]
9. [Chronic intermittent urokinase therapy in therapy-refractory angina pectoris].
Leschke M; Höffken H; Motz W; Blanke H; Schöbel F; Strauer BE
Dtsch Med Wochenschr; 1992 Jan; 117(3):81-7. PubMed ID: 1730212
[TBL] [Abstract][Full Text] [Related]
10. [Pseudostabilization of unstable angina pectoris: disappearance of symptoms in persistence of silent myocardial ischemia].
Hausmann D; Gulba D; Nikutta P; Lichtlen PR
Z Kardiol; 1988 Dec; 77(12):805-10. PubMed ID: 2977870
[TBL] [Abstract][Full Text] [Related]
11. Prolonged urokinase infusion for chronic total native coronary occlusions: clinical, angiographic, and treatment observations.
Ajluni SC; Jones D; Zidar F; Puchrowicz S; Margulis A; O'Neill WW; Grines CL
Cathet Cardiovasc Diagn; 1995 Feb; 34(2):106-10; discussion 111. PubMed ID: 7788687
[TBL] [Abstract][Full Text] [Related]
12. [Rheology and coronary heart disease].
Leschke M
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S270-3. PubMed ID: 19085805
[TBL] [Abstract][Full Text] [Related]
13. [Therapy refractory end stage angina pectoris in coronary heart disease--a clinical and scientific challenge].
Leschke M; Schoebel FC; Strauer BE
Z Kardiol; 1997; 86 Suppl 1():V-VI. PubMed ID: 9173715
[No Abstract] [Full Text] [Related]
14. [Symptomatic therapy refractory myocardial ischemia in coronary heart disease. Chronic intermittent urokinase therapy and invasive therapeutic measures].
Leschke M; Schoebel FC; Strauer BE
Internist (Berl); 1996 Jun; 37(6):597-606. PubMed ID: 8767992
[No Abstract] [Full Text] [Related]
15. Prolonged intragraft urokinase with a new infusion wire: improved short-term results.
Cundey PE; Whitlock RR; Norman J; Edwards M; Cundey PE
Cathet Cardiovasc Diagn; 1994 Feb; 31(2):150-2. PubMed ID: 8149430
[TBL] [Abstract][Full Text] [Related]
16. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory angina pectoris.
Gowda RM; Khan IA; Punukollu G; Vasavada BC; Nair CK
Int J Cardiol; 2005 May; 101(1):1-7. PubMed ID: 15860376
[TBL] [Abstract][Full Text] [Related]
18. [Preinfarction angina and coronary thrombolysis].
Fujii B; Takashiba K; Hamada Y; Ohno H; Ebihara H; Hyakuna E; Matsuda Y
Kokyu To Junkan; 1988 Oct; 36(10):1109-11. PubMed ID: 3247526
[No Abstract] [Full Text] [Related]
19. [Characteristics of angina pectoris therapy with nitrates].
Silber S
Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
[TBL] [Abstract][Full Text] [Related]
20. [Therapy-refractory angina pectoris. Pathophysiologic basis and evaluation of alternative therapies].
Schoebel FC; Leschke M; Strauer BE
Dtsch Med Wochenschr; 1995 Mar; 120(9):301-7. PubMed ID: 7875081
[No Abstract] [Full Text] [Related]
[Next] [New Search]
